| |
| |
|
| Insider
Information: |
Jaeger Wilfred E |
| Relationship: |
Director |
| City: |
Portola Valley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
200,655 |
|
|
Indirect Shares
|
6,921,311 |
|
|
| Direct
Value |
$667,729 |
|
|
|
Indirect Value
|
$599,399 |
|
|
| Total
Shares |
7,121,966 |
|
|
| Total
Value |
$1,267,128 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
North American Scientific Inc |
NASMQ |
Director |
|
0 |
2006-06-14 |
5,121,638 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
Director |
2015-11-24 |
52,500 |
2014-01-16 |
0 |
Premium* |
|
|
Epocrates Inc |
EPOC |
Former 10% Owner |
2011-02-07 |
0 |
2011-02-07 |
1,655,329 |
Premium* |
|
|
Liposcience Inc |
LPDX |
10% Owner |
|
0 |
2013-01-30 |
83,739 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director |
2023-03-06 |
0 |
2014-11-18 |
29,052 |
Premium* |
|
|
Nevro Corp |
NVRO |
Director |
2020-05-21 |
9,592 |
2020-05-21 |
31,553 |
Premium* |
|
|
Neuronetics Inc |
STIM |
Director |
2023-05-25 |
138,563 |
2018-07-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STIM |
Neuronetics Inc |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
36,364 |
138,563 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,400) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,125) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
21,525 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
38,910 |
102,187 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,125 |
5,125 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2021-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,137 |
63,289 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2020-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
18,513 |
56,152 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
37,639 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,376 |
9,592 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2020-01-02 |
4 |
A |
$4.49 |
$13,748 |
D/D |
3,062 |
17,639 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2019-10-01 |
4 |
A |
$8.30 |
$16,243 |
D/D |
1,957 |
14,577 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2019-07-01 |
4 |
A |
$12.51 |
$16,238 |
D/D |
1,298 |
12,620 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2019-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,723 |
11,322 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,913 |
8,216 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2019-04-01 |
4 |
A |
$14.75 |
$13,747 |
D/D |
932 |
7,599 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2018-07-02 |
4 |
B |
$17.00 |
$113,339 |
D/D |
6,667 |
6,667 |
2.39 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2018-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,785 |
5,303 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2018-03-07 |
4 |
S |
$81.42 |
$5,503,001 |
I/I |
(67,586) |
11,042 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2018-03-06 |
4 |
S |
$80.38 |
$4,086,555 |
I/I |
(50,840) |
12,503 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2018-03-05 |
4 |
S |
$80.19 |
$3,377,114 |
I/I |
(42,116) |
13,601 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2018-03-01 |
4 |
S |
$80.48 |
$804,843 |
I/I |
(10,000) |
14,511 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2018-02-28 |
4 |
S |
$81.36 |
$1,234,321 |
I/I |
(15,000) |
14,727 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2018-02-27 |
4 |
S |
$83.20 |
$1,204,045 |
I/I |
(14,458) |
15,051 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2017-09-14 |
4 |
S |
$89.72 |
$1,485,206 |
I/I |
(16,467) |
20,764 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
